Oral phenylalanine loading in dopa-responsive dystonia: A possible diagnostic test

Neurology

Volumn 48, Issue 5, 1997, Pages 1290-1297

  Hyland, Keith ^a,b   Fryburg, J S ^e   Wilson, W G ^e   Bebin, E M ^d   Arnold, L A ^a   Gunasekera, R S ^a   Jacobson, R D ^c   Rost Ruffner, E ^e   Trugman, J M ^e  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPTERIN; DOPA; NEOPTERIN; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TETRAHYDROBIOPTERIN; TYROSINE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DYSTONIA; ENZYME ACTIVITY; FEMALE; HUMAN; LOADING TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030898773     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.5.1290     Document Type: Article

References (43)

1. Segawa M, Hosaka A, Miyagawa F, et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976;14:215-233.
2. Nygaard TG. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 1993; 60:577-585.
3. Nygaard TG, Waren SP, Levine RA, Naini AB, Chutorian AM. Dopa-responsive dystonia simulating cerebral palsy. Pediatr Neurol 1994;11:236-240.
4. Fink JK, Filling-Katz MR, Barton NW, Macrae PR, Hallett M, Cohen WE. Treatable dystonia presenting as spastic cerebral palsy. Pediatrics 1988;82:137-138.
5. Boyd K, Patterson V. Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy. BMJ 1989;298: 1019-1020.
6. Marsden CD, Quinn NP. The dystonias. BMJ 1990;300:139-144.
7. Fletcher NA, Thompson PD, Scadding JW, Marsden CD. Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 1993;56:865-867.
8. Nygaard TG, Wilhelmsen KC, Risch NJ, et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993;5:386-391.
9. Ichinose H, Ohye T, Takahashi EI, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8: 236-242.
10. Nagatsu T, Levitt M, Udenfriend S. Tyrosine hydroxylase, the initial step in norepinephrine biosynthesis. J Biol Chem 1964; 238:2910-2917.
11. Kaufman S. Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine. J Biol Chem 1959;234: 2677-2682.
12. Dhondt JL. In: Milupa, ed. Register of tetrahydrobiopterin deficiencies. Bagnolet: Les Mercurials 1991.
13. Blau N, Dhondt JL. Tetrahydrobiopterin deficiency and an international database of patients. In: Ayling JE, Nair MG, Baugh CM, eds. Advances in experimental medicine and biology. New York: Plenum Press, 1993;338:205-261.
14. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995;1015-1075.
15. Trugman JM, Hyland K, Fryburg JS, et al. Peripheral biopterin defect in dopa-responsive dystonia demonstrated with a phenylalanine load test. Mov Disord 1995;10:698.
16. Hyland K, Trugman JM, Rost-Ruffner E, et al. Abnormal phenylalanine metabolism in dopa-responsive dystonia: a possible diagnostic test. Neurology 1996;46:A273.
17. Hyland K, Smith I, Howells DW. An isocratic high-performance liquid chromatographic system for the investigation of abnormalities of neurotransmitter amine, biopterin, and aromatic amino acid metabolism in cerebrospinal fluid using sequential coulometric electrochemical and fluorescence detection. In: Joseph MH, Fillenz M, Macdonald IA, Marsden CA, eds. Monitoring neurotransmitter release during behaviour. Ellis Howard UK, 1986;233-238.
18. Fukushima T, Nixon JC. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980;102: 176-188.
19. Harada T, Kagamiyama H, Hatakeyama K. Feedback regulation mechanisms for control of GTP cyclohydrolase I activity. Science 1993;260:1507-1510.
20. McDonald JD, Cotton RGH, Jennings I, Ledley FD, Woo SLC, Bode VC. Biochemical defect of the HPH-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity. J Neurochem 1988; 50:655-657.
21. Hyland K, Gunasekera RS, Engle T, Arnold LA. Tetrahydrobiopterin and biogenic amine metabolism in the HPH-1 mouse. J Neurochem 1996;67:752-759.
22. McDonald JD, Bode VC. Hyperphenylalaninaemia in the hph-1 mouse mutant. Pediatr Res 1988;23:63-67.
23. Takahashi H, Levine RA, Galloway MP, Snow BJ, Calne DB, Nygaard TG. Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol 1994;35:354-356.
24. Williams A, Eldridge R, Levine R, Lovenberg W, Paulson G. Low CSF hydroxylase cofactor (tetrahydrobiopterin) levels in inherited dystonia. Lancet 1979;2:410-411.
25. Le Witt PA, Miller LP, Levine RA, et al. Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials. Neurology. 1986;36:760-764.
26. Fink JK, Barton N, Cohen W, Lovenberg W, Burns RS, Hallett M. Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 1988;38:707-711.
27. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160:310-316.
28. Niederwieser A, Blau N, Wang M, Joller P, Atar M, Cardesa-Garcia J. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine and serotonin deficiencies and muscular hypotonia. Eur J Pediatr 1984;141:208-214.
29. Brown ES, Waisman HA, Swanson MA, Colwell RE, Banks ME, Gerritsen T. Effects of oral contraceptives and obesity on carrier tests for phenylketonuria. Clin Chim Acta 1973;44: 183-192.
30. Wurtman RJ, Rose CM, Chou C, Larin FF. Daily rhythms in the concentrations of various amino acids in human plasma. N Engl J Med 1968;279:171-178.
31. Jagenburg R, Regardh CG, Rodjer S. Influence of age and sex on the kinetics of intravenously administered L-phenylalanine. Clin Chem 1982;28:204-206.
32. Rose DP, Cramp DG. Reduction of plasma tyrosine by oral contraceptives and oestrogens: A possible consequence of tyrosine aminotransferase induction. Clin Chim Acta 1970;29:49-53.
33. Westwood A, Raine DN. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio. J Med Genet 1975;12:327-333.
34. Rampini S, Anders PW, Curtius HCh, Marthaler TH. Detection of heterozygotes for phenylketonuria by column chromatography and discriminatory analysis. Pediatr Res 1969;3: 287-297.
35. Saraiva JM, Seakins JWT, Smith I. Plasma phenylalanine and tyrosine levels revisited in heterozygotes for hyperphenylalaninemia. J Inherit Metab Dis 1993;16:105-109.
36. Leeming RJ, Blair A, Green A, Raine DN. Bioptenn derivatives in normal and phenylketonuric patients after oral load of L-phenylalanine, L-tyrosine and L-tryptophan. Arch Dis Child 1976;51:771-777.
37. Dhondt JL, Farriaux JP. Relationships between phenylalanine and biopterin metabolism. In: Wachter H, Curtius HCh, Pfleiderer W, eds. Biochemical and clinical aspects of pteridines. Berlin: Walter de Gruyter, 1982;1:318-328.
38. Dhondt JL, Lerox B, Farriaux JP, Largilliere C, Leeming RJ. Dihydrobiopterin biosynthesis deficiency. Eur J Pediatr 1983; 141:92-95.
39. Alös T, Bel Y, Cabello ML, et al. Improved identification of heterozygotes for phenylketonuria using blood neopterin and biopterin. J Inherit Metab Dis 1993;16:457-464.
40. Danks DM, Schlesinger P, Firgaira F, et al. Malignant hyperphenylalaninemia - clinical features, biochemical findings and experience with administration of biopterins. Pediatr Res 1979;13:1150-1155.
41. Tanaka K, Yoneda M, Nakajima T, Miyatake T, Owada I. Dihydrobiopterin synthesis defect: an adult with diurnal fluctuations of symptoms. Neurology 1987;37:519-522.
42. Knappskog PM, Flatmark T, Mallet J, Lüdecke B, Bartholomé K. Recessively inherited L-dopa-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995:4;1209-1212.
43. Lüdecke B, Dworniczak B, Bartholomé K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 1995;93:123-125.